Magnetic resonance imaging-guided focal laser ablation is used as alternative to radical treatment while preserving healthy tissue and subsequently reduce treatment-related morbidity in patients with localized prostate cancer. Preliminary results of this prospective, non-randomized, clinical phase 2 study using a remote-controlled manipulator, show promising results in both oncological and functional outcomes in a group of 20 patients with low- to intermediate-risk (Gleason Score ≤ 4+3) prostate cancer. Transrectal magnetic resonance imaging-guided focal laser ablation is a promising outpatient procedure under local anesthesia for localized prostate cancer. It provides a fast and minimally-invasive strategy while reducing treatment related complications and side-effects.
This abstract and the presentation materials are available to members only; a login is required.